Pyridine → HCID 86686781, compound
Reaction equation
[F:1][CH:2]([F:32])[C:3]1[N:7]([C:8]2[N:13]=[C:12]([N:14]3[CH2:19][CH2:18][O:17][CH2:16][CH2:15]3)[N:11]=[C:10]([NH:20][CH2:21][CH:22]3[CH2:27][CH2:26][NH:25][CH2:24][CH2:23]3)[N:9]=2)[C:6]2[CH:28]=[CH:29][CH:30]=[CH:31][C:5]=2[N:4]=1.N1C=CC=CC=1.[C:39](OC(=O)C)(=[O:41])[CH3:40]>C1(C)C=CC=CC=1>[C:39]([N:25]1[CH2:24][CH2:23][CH:22]([CH2:21][NH:20][C:10]2[N:9]=[C:8]([N:7]3[C:6]4[CH:28]=[CH:29][CH:30]=[CH:31][C:5]=4[N:4]=[C:3]3[CH:2]([F:1])[F:32])[N:13]=[C:12]([N:14]3[CH2:19][CH2:18][O:17][CH2:16][CH2:15]3)[N:11]=2)[CH2:27][CH2:26]1)(=[O:41])[CH3:40]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a mixture of 4-[2-(difluoromethyl)-1H-benzimidazol-1-yl]-6-morpholin-4-yl-N-(piperidin-4-ylmethyl)-1,3,5-triazin-2-amine (50 mg) and pyridine (2 mL) was added acetic anhydride (14 μL), and the mixture was stirred at room temperature overnight. To the reaction mixture was added toluene, followed by concentrating under reduced pressure. The residue was dissolved in dichloromethane, and silica gel was added thereto, followed by concentrating under reduced pressure. The residue was purified by silica gel column chromatography (hexane:ethyl acetate, and subsequently chloroform:methanol) to obtain N-[(1-acetylpiperidin-4-yl)methyl]-4-[2-(difluoromethyl)-1H-benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazine-2-amine (44 mg) as a white powder.
Workup
- concentrationby concentrating under reduced pressure
- dissolutionThe residue was dissolved in dichloromethane
- additionsilica gel was added
- concentrationby concentrating under reduced pressure
- customThe residue was purified by silica gel column chromatography (hexane
Sources & evidence
- ORD record
- ord-c439e1e4e98f4b2ba292b722bc99b63d
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08912180B2
Reaction notes
Loading…